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Abstract
Background: We report our approach regarding the technique of endoscopic extraperitoneal
radical prostatectomy (EERPE) and analyze the learning curve of two surgeons after thorough
technical training under expert monitoring. The purpose of this study was to investigate the
influence of expert monitoring on the surgical outcome and whether previous laparoscopic
experience influences the surgeon's learning curve.
Methods: EERPE was performed on 120 consecutive patients by two surgeons with different
experience in laparoscopy. An analysis and comparison of their learning curve was made.
Results: Median operation time: 200 (110 – 415) minutes. Complications: no conversion, blood
transfusion (1.7%), rectal injury (3.3%). Median catheterisation time: 6 (5 – 45) days.
Histopathological data: 55% pT2, 45% pT3 with a positive surgical margin rate of 6.1% and 46%,
respectively. After 12 months, 78% of the patients were continent, 22% used 1 or more pad.
Potency rate with or without PDE-5-inhibitors was 66% with bilateral and 31% with unilateral
nerve-sparing, respectively. Operation time was the only parameter to differ significantly between
the two surgeons.
Conclusion:  EERPE can be learned within a short teaching phase. Previous laparoscopic
experience is reflected by shorter operation times, not by lower complication rates or superior
early oncological data.
Background
The initial step towards minimally invasive surgical treat-
ment of localized prostate cancer was made by Schuessler
et al. in the early Nineties with his description of a lapar-
oscopic radical prostatectomy (LRP) [1]. However, the
first larger series of LRP was published by Guillonneau et
al. in 1999 [2]. After Raboy et al. described an extraperito-
neal approach to the prostate in 1997 [3], Bollens et al.
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presented a series of 50 cases of EERPE in 2001 [4]. Based
on his technique, further modifications were developed
by Stolzenburg et al. [5-7] who established EERPE as a first
– line minimally – invasive procedure for localized pros-
tate cancer, suitable even for patients who had undergone
previous abdominal surgery [8].
In view of the satisfactory oncological results of EERPE [9]
and general post-operative advantages of laparoscopic
compared to open surgery, we decided to establish EERPE
at our hospital in March 2004. In this article we describe
our experiences in learning EERPE and present the opera-
tive data and one year follow-up of the first 120 cases
including a comparison of the learning curves of two sur-
geons with differing degrees of laparoscopic experience.
Methods
Surgeon characteristics and initial steps
Two surgeons commenced operative training simultane-
ously. Surgeon 1 (S1) had 7 years of laparoscopic experi-
ence, whereas surgeon 2 (S2) had only two years of
experience in urological laparoscopy. Details of the lapar-
oscopic procedures performed by both surgeons are given
in Table 1. Both had performed over 50 cases of open ret-
ropubic radical prostatectomy, whereas neither of them
was experienced in laparoscopic radical prostatectomy.
After studying multi media material, both surgeons were
trained in a dry lab (pelvic trainer) and on a porcine
model for 4 weeks. During one week of training in a high-
volume centre, each surgeon attended 6 procedures (cam-
era and assistance) of EERPE. Back at our hospital, 9 con-
secutive procedures were supervised by experts in the
technique. Patient pre – selection was not made for either
surgeons.
Patient characteristics
Between April 2004 and April 2005, 120 consecutive
patients underwent EERPE performed by two surgeons.
This study was carried out with the approval of the local
ethics committee of the University of Regensburg and all
patients gave written informed consent before participat-
ing in the study. Baseline characteristics are shown in
Table 2. 47 (39.2%) patients had had previous surgery:
open inguinal hernia repair (n = 21), open appendectomy
(n = 17), transurethral resection of the prostate (n = 3),
open cholecystectomy (n = 2), laparoscopic cholecystec-
tomy (n = 1), gastrectomy (n = 1), umbilical hernia repair
(n = 1) and partial bowel resection (n = 1). 10 (8.3%)
patients had neo-adjuvant hormonal therapy (3 – 12
weeks).
Oncological and functional follow-up
All patients were followed up every three months by a self-
administered questionnaire sent by mail, including a
stamped return envelope addressed to our institution.
Erectile function was evaluated by the short form of the
international index of erectile function questionnaire
(IIEF 5). The possible scores for the IIEF-5 range from 5 to
25, and erectile dysfunction (ED) was classified into five
categories based on the following scores: severe (5–7),
moderate (8–11), mild to moderate (12–16), mild (17–
21) and no ED (22–25) [10]. Continence was evaluated
by a question concerning pad use. Patients were consid-
ered continent if they did not require protection. Our fol-
low-up schedule included PSA measurements at 3-
monthly intervals and questions on adjuvant therapy.
Biochemical failure was defined as any measurable PSA
greater than 0.2 ng/mL.
Technique
EERPE was performed using the technique described by
Stolzenburg et al. Pelvic lymph node dissection was per-
formed in patients with PSA ≥ 10 ng/ml and/or a Gleason-
score ≥ 7. Criteria for a nerve-sparing technique were as
follows: no preoperative erectile dysfunction, PSA ≤ 10
ng/mL, Gleason score ≤ 6 and no palpable tumour on the
nerve-sparing side.
Table 1: Laparoscopic operations performed by surgeon 1 & surgeion 2 before starting training for EERPE
Laparoscopic operations Number of operations
Surgeon 1 Surgeon 2
Varicocele ligation 82 19
Pelvic staging lymph node dissection 25 4
Modified retroperitoneal lymph node dissection 3
Tumor nephrectomy 1
Simple nephrectomy 12
Nehproureterectomy 4
Pyeloplasty 13
Cyst decortication 5
Adhesiolysis 13
Lymphocele fenestration 19 2BMC Urology 2007, 7:11 http://www.biomedcentral.com/1471-2490/7/11
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Statistical analysis of the learning curve
After analyzing all important parameters a separate analy-
sis of the learning curve was made according to the speci-
fication of three phases. Phase 1: Expert supervision of the
first 9 operations (S1 n = 7, S2 n = 2). Phase 2: 16 opera-
tions performed by the same team with S1 and S2 assist-
ing each other (S1 n = 9, S2 n = 7). Phase 3: 95 operations
with varying assistants (S1 n = 50, S2 n = 45). Thereafter
the data of S1 and S2 were compared. Contingency table
analysis and two-sided Fisher's exact tests were used to
study the association between categorical variables. The
two-sided Mann-Whitney U-test was used for the non-par-
ametric comparison of two independent metric variables.
Differences between three independent metric variables
were tested with the two-sided Kruskal-Wallis test. P val-
ues < 0.05 were considered significant. Statistical analyses
were completed using SPSS version 10.0 (SPSS, Chicago,
IL, USA). The closed test principle was used for multiple
testing.
Results
Peri-operative data
The median operation time was 200 minutes (range 110
– 415). Pelvic lymph node dissection was performed in 26
(21.7%) patients, unilateral nerve-sparing in 26 (21.7%)
and bilateral nerve-sparing in 5 (4.2%) cases. The median
aspirated blood/urine mixture was 300 ml (range 100 –
3000). 2 (1.7%) patients received blood transfusion
within 24 h post-operatively. There was no conversion to
open surgery or early reintervention.
Postoperative management
The median catheterisation time was 6 days (range 5 – 45,
mean 7.1). A routinely performed radiological control
showed a leakage of the vesicourethral anastomosis in 9
(7.5%) patients on day 6.
Intra-operative complications
A patient with a history of stable coronary heart disease
and previous myocardial infarction developed intraoper-
ative cardiac shock due to myocardial reinfarction and
died 14 h postoperatively. During the development of the
preperitoneal space major bleeding occurred in one
patient due to injury of the epigastric vessels, this being
stopped immediately by endoclips. Intra-operative rectal
injury occurred in 4 (3.3%) patients during the prepara-
tion of the prostate apex. Once recognized the defect was
closed in two layers (Vicryl 2/0). A rectal catheter was
inserted and intravenous antibiotics were administered
for 3 days. Food intake was not delayed. No patient
required a diverting colostomy.
Early post-operative complications
After intra-operative deterioration of the respiratory
parameters, one patient developed acute respiratory dis-
tress syndrome (ARDS) but recovered completely after
prolonged intensive-care treatment. Three weeks after reg-
ular discharge from hospital one patient presented with a
vesicorectal fistula requiring temporary colostomy and
suprapubic catheterisation of the bladder for 9 weeks with
consecutive spontaneous closure of the defect. Sympto-
matic pelvic lymphocele occurred in 2 (1.7%) and was
treated by laparoscopic intervention. Due to 2nd degree
hydronephrosis one patient required a temporary neph-
rostomy. No patient developed ileus, deep venal throm-
bosis, pulmonary embolism or nosocomial pneumonia.
Histopathological results
Histopathological stage was defined according to the
TNM classification (UICC 2002). The distribution is
shown in Table 3.
Oncological follow-up
In our series, 7 (5.8%) patients experienced PSA failure
during the first year. In 4 of these patients, adjuvant ther-
apy was initiated (anti-hormonal therapy in 3 patients,
radiation in 1 patient).
Functional follow – up
84 (70%) patients completed the functional follow-up.
Of these patients, 62 (74%) patients were completely con-
tinent (no pads) 6 months after surgery. 17 (20%)
patients reported the daily use of 1 to 2 pads, whereas 5
(6%) patients used more than 2 pads. 12 months post-
operatively, 64 (78%) patients were continent, 14 (17%)
used 1 to 2 pads and 4 (5%) patients used more than 2
pads.
A 12-month functional follow-up was completed by 3 of
5 (60%) patients with bilateral nerve-sparing and by 13 of
26 (50%) patients with unilateral nerve-sparing. In the
bilateral nerve-sparing group, 2 of 3 (66%) had an IIEF
score > 17 and sexual intercourse was possible with or
without PDE 5 inhibitors. 1 of 13 (8%) patients with uni-
Table 2: Patient characteristics and baseline data
number of patients 120
median age in years (range) 65 (4.1 – 76)
median PSA in ng/mL (range) 8.68 (1.1 – 29.9)
median prostate volume in mL (range) 30.9 (9 – 87)
median Gleason score (range) 6 (3 – 10)BMC Urology 2007, 7:11 http://www.biomedcentral.com/1471-2490/7/11
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lateral nerve-sparing had an IIEF score > 17 and 4 of 13
(31%) reported erectile function sufficient for sexual
intercourse with the help of PDE 5 inhibitors.
Analysis of the learning curve
Comparison of 3 phases
Analysis of the median operation time shows an initial
increase from 190 (range 160 – 235) minutes in phase 1
(9 operations under expert supervision) to 234 (range 155
– 350) minutes in phase 2 (16 operations with S1 and S2
assisting each other). Thereafter, median operation time
decreased slightly to 195 (range 110 – 415) minutes in
phase 3 (95 operations with varying assistants, Figure 1A).
However, the differences were not statistically significant
(p = 0.054; Table 4). Furthermore, the rate of positive sur-
gical margins was not significantly different in relation to
the different training phases (p = 1.000; Table 4). The
number of intra-operative and postoperative complica-
tions within the 3 training phases did not differ signifi-
cantly (p = 0.081, p = 1.000; Table 4).
Comparison of both surgeons
The overall median operation time was significantly
shorter for S1 (p < 0.001, Table 4, Figure 1A). Apart from
the operation time, no significant difference concerning
intra- and post-operative complications could be found
between either of the two surgeons (Table 4). In detail,
intra-operative injury of the epigastric vessels was caused
by S1, all rectal injuries (4) by S2. Cardiac shock occurred
in a patient operated on by S1. Reintervention for recto-
vesical fistula and hydronephrosis was necessary after
operations performed by S1, whereas the occurrence rate
of symptomatic pelvic lymphocele was equal for both sur-
geons. The positive surgical margin rate was not signifi-
cantly different between either of the two surgeons (p =
1.000).
Discussion
Laparoscopic radical prostatectomy has made impressive
progress in the treatment of organ-confined prostate can-
cer since the first description by Schuessler et al. in 1991
Table 3: Oncological results
Tumour stage
pT2 (%) 66 (55)
pT2a (%) 21 (17.5)
pT2b (%) 3 (2.5)
pT2c (%) 42 (35)
pT3 (%) 54 (45)
pT3a (%) 39 (32.5)
pT3b (%) 15 (12.5)
Lymph node status
PNx (%) 94 (78.3)
pN0 (%) 22 (18.3)
pN 1–2 (%) 4 (3.3)
Gleason score
<7 (%) 70 (58.3)
≥7 (%) 50 (41.7)
Surgical margin status
R0 (%) 91 (75.8)
R1 (%) 29 (24.2)
R1 among pT2 (%) 4 (6.1)
R1 among pT2a (%) 1 (4.7)
R1 among pT2b (%) 0
R1 among pT2c (%) 3 (7.1)
R1 among pT3 (%) 25 (46)
R1 among pT3a (%) 20 (51)
R1 among pT3b (%) 5 (33.3)BMC Urology 2007, 7:11 http://www.biomedcentral.com/1471-2490/7/11
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[11]. The main objective in establishing the technique was
to combine cure rates of open radical prostatectomy with
the low morbidity of minimally-invasive procedures.
Meanwhile, laparoscopic radical prostatectomy is the
first-line option in the treatment of organ-confined pros-
tate cancer in selected centres [12-14]. Nevertheless,
despite being attractive, EERPE is restricted to a few cen-
tres as a result of its demanding technical requirements
and the length of the learning curve. Therefore, a crucial
issue when establishing the procedure in a hospital is the
initial approach and overcoming of the learning curve.
With the present study we are contributing towards to an
assessment of the feasibility of this surgical approach. The
special feature in our learning curve is the short teaching
phase of only 9 operations under expert monitoring.
Operation time
Using the transperitoneal approach, Guillonneau et al.
report a mean operation time of 203 minutes after 567
cases [15], with 268 minutes in the first 50 operations.
Rassweiler et al. report 324 minutes of mean operation
time in the first 60 sessions and 265 minutes in the last
120 [16]. In the case of the extraperitoneal approach sig-
nificantly shorter mean operation times are reported by
Stolzenburg et al., namely 151 minutes after 700 cases.
With a mean operation time of 206 minutes, our results
are encouraging, whilst a further decrease in operation
time is anticipated.
Transfusion and conversion rate
Most groups report a decrease in blood transfusion rates
during the learning curve[17,18]. In relevant literature,
transfusion rates from 0.9% (Stolzenburg et al.) [19] to
31% (Rassweiler et al.) [20] are reported. With a perioper-
ative transfusion rate of 1.7% we achieved encouraging
results in our series. Furthermore, similar to the series
described by Turk et al. [21], Gregori et al. [22] and
Stolzenburg et al. [23], we did not experience any imme-
diate conversion to open surgery, whereas other groups
report conversion rates up to 4.4% [24].
Complications
Complications commonly occur during the first cases and
decrease with the surgeon's experience [25]. In our series,
this particular apect cannot be confirmed, considering our
4 (3.3%) cases of rectal injury which occurred not during
the first operations, but in phase 3. However, this compli-
cation rate is still within the limits of other groups' expe-
riences, which range from 0.6% [26] to 6.8% [27]. Beyond
that, our series shows a generally low rate of intraopera-
tive and early post-operative complications (Table 4).
Histopathological results
When introducing laparoscopic radical prostatectomy a
major goal must be to achieve oncological results compa-
rable to those of other high volume centres. In this con-
text, an important feature is the rate of positive surgical
margins derived from pathological examination of the
surgical specimen, as it represents an important prognos-
tic factor [28]. Positive surgical margins after LRP range
from 11.4% (Dahl et al.) [29], 20% (Stolzenburg et al.)
[30] up to 34% by a "junior surgeon" under supervision
during his early learning curve (El-Feel et al.) [31]. Our
overall positive surgical margin rate was 24.2% with a rel-
atively low rate of 6.1% concerning stage pT2 tumours.
Functional und oncological follow-up
Classification of the degree of incontinence after radical
prostatectomy is an important factor for quality control.
However, there is no widespread use of a validated conti-
nence questionnaire and in almost all publications the
continence status is evaluated by the number of pads used
by the patient [32-34]. In order to compare our data with
other groups, we evaluated the "pad situation" in our
series, which is comparable with other publications [35].
However, the number of pads is not an unequivocable
tool to measure incontinence, as it depends strongly on
the patient's habits and the amount of urine in the pad
when it is changed.
Regarding PSA follow-up, it is essential to consider, that
one year is a relatively short follow-up time to evaluate the
oncological aspect of radical prostatectomy, as biochemi-
Table 4: Comparison of phases and surgeons
Phase 1 Phase 2 Phase 3 p S1 S2 p
no. of operations 9 16 95 70 50
median operation time in minutes (range) 190 (160–235) 234 (155–350) 195 (110–415) 0.054 180 (110–350) 227 (158–415) < 0.001
median catheterisation time in days (range) 6 (6-6) 6 (6-6) 6 (6–45) 0.066 6.0 (6–45) 6.0 (6–40) 0.285
no. of intraoperative complications 0 0 6 0.746 1 5 0.081
no. of postoperative complications 1 0 7 0.372 5 3 1.000
no. of positive surgical margins (%) 2 (22.2) 3 (20) 24 (25.3) 0.924 16 (22.8) 13 (26) 1.000
bold face representing significant data.BMC Urology 2007, 7:11 http://www.biomedcentral.com/1471-2490/7/11
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cal failure during the first year is mostly due to systemic
and not to local recurrence [36]. However, our biochemi-
cal recurrence rate of 5.8% resembles the experiences of
other groups [37] and reflects the high number of pT3
tumors in this series. However, Stolzenburg et al., pio-
neers in EERPE, had the same rate in pT3 tumours in their
series of 700 patients [38].
Learning curve
Our initial steps towards gaining proficiency in EERPE are
similar to those described by Bollens et al. with respect to
the steps of dry lab, animal live lab and mentoring with an
expert [39]. Our teaching phase commenced with rela-
tively short median operation times (190 minutes, phase
1), showing the influence of expert supervision. The rise
in median operation time to 234 minutes (phase 2)
reflects a phase of uncertainty and lack of supervision.
However, after only 25 operations we felt comfortable
enough to rotate the operating teams in order to instruct
new assistants (phase 3) and achieved shorter operation
times. Mean catheterisation time and the occurrence of
complications were not influenced by the learning curve
as was the case in other groups [40]. Furthermore, the rate
of positive surgical margins remained stable and did not
differ significantly in the different stages of the learning
curve.
Comparing the learning curves of both surgeons, the
impact of superior experience in laparoscopy is only
reflected by significantly shorter operation times. Despite
differing degrees of laparoscopic experience, the two sur-
geons did not differ significantly as regards positive surgi-
cal margin rates, this, in contrast, being described by other
groups [41].
A shortcoming of our study is the retrospective character
of the analysis with a relatively small number of patients.
Although the results of this paper reflect a typical
approach to establish laparoscopic procedures in a hospi-
tal, prospective studies are needed to analyse learning
curves of surgeons and to find a way to overcome these.
Conclusion
Our series of EERPE performed on 120 patients shows
results comparable to those of other high-volume centres
as regards peri-operative data, patient morbidity and early
functional and oncological outcomes. EERPE can be
learned after thorough technical training under expert
monitoring within a short teaching phase. Previous lapar-
oscopic experience is reflected by shorter operation times
but similar complication rates and oncological results.
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